US FDA approves Gilead’s antiviral remdesivir for treatment of COVID-19.

 In Uncategorized

Based on the strength of data, Veklury (remdesivir) has become the standard of care for the treatment of COVID-19 in hospitalized patients.  Remdesivir can speed up recovery time and lesson rates of progression to mechanical ventilation while providing critical hope to loved ones and healthcare providers.

Recent Posts

Leave a Comment